Cleerly · 5 hours ago
Analyst, Core Lab-Imaging Services (Pacific Hours)
Cleerly is a healthcare company focused on revolutionizing heart disease diagnosis and treatment. They are seeking an Analyst for their Core Lab Imaging Services team, responsible for analyzing AI-generated outputs from Coronary CTA exams and ensuring image quality. This role is primarily remote with some required travel for training and meetings.
AppsArtificial Intelligence (AI)Health CareMedicalWellness
Responsibilities
Analyze outputs generated by artificial intelligence from Coronary CTA exams
Evaluate Coronary CTA exams for image quality
Perform administrative duties as required
Support to the Applications Team liaising with sites, if necessary
Participation in continuous improvement projects
Comply with process and quality standards
Qualification
Required
Associates Degree in Radiography
ARRT certification
High attention to detail
Great interpersonal skills - must be able to work well in a team environment
Desire and ability to learn new technologies - willing to learn
Mostly remote work from home, so must have high speed internet
Shift work, including evenings and weekends possible in the future
Some travel (2-4 weeks per year expected, but may vary)
Reside in New York (tri-state area included) or Denver, CO
Able to work pacific time and/or evening shifts from other time zones to provide required time zone coverage
Valid US passport
Preferred
Experience in CT a plus, but not required
Coronary CTA or 3D post-processing experience is a plus, but not required
Company
Cleerly
Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.
H1B Sponsorship
Cleerly has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Growth StageTotal Funding
$386.48MKey Investors
Insight PartnersVensana Capital
2024-12-03Series C· $106M
2022-07-25Series C· $223M
2021-06-21Series B· $43M
Leadership Team
Recent News
2025-11-27
Company data provided by crunchbase